Catalyst Crew Technologies Corp., a digital health and artificial intelligence technology company focused on emerging markets, announced the assignment of three Venezuelan patents to its wholly-owned Venezuelan operating subsidiary, Inversiones Long 33, C.A. The intellectual property, previously held by CEO Dr. Kevin Rodan Levy, includes proprietary technologies known as CardioAI, PulmoAI, and NeuroAI, designed for healthcare analytics, predictive modeling, and clinical decision-support applications.
This strategic move aligns the company's intellectual property with its operational structure, positioning the subsidiary as the primary vehicle for development and commercialization in the region. The consolidation aims to enhance strategic flexibility, support regulatory alignment, and potentially facilitate future partnerships, licensing opportunities, and regional expansion. The company believes this foundational step is crucial for advancing its platform, which focuses on scalable healthcare solutions including telehealth infrastructure, remote patient monitoring, and advanced analytics to improve access and care coordination.
In addition to the Venezuelan assignment, Catalyst Crew Technologies intends to pursue expanded intellectual property protection for its technologies in additional jurisdictions worldwide, supporting long-term platform development and potential international deployment. Dr. Kevin Rodan Levy stated that establishing a clear foundation around core technologies enables progress in development, partnerships, and broader intellectual property strategies across markets. The company continues to advance its AI-driven healthcare platform, initially emphasizing Latin America, through technology development, strategic partnerships, and targeted acquisitions.
The importance of this development lies in its implications for digital health innovation in emerging markets, where access to advanced healthcare technology remains limited. By formally structuring its intellectual property assets, Catalyst Crew Technologies seeks to strengthen its position in a growing sector, potentially influencing how AI and data analytics are deployed to address healthcare disparities. The move may signal increased activity in the digital health space within Latin America and other emerging regions, as companies seek to protect and commercialize proprietary technologies. For more information, the company directs stakeholders to its website at https://catalystcrewai.com or its filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.
